Clinical trial

Effects of Acipimox on Insulin Action, Vascular Function, and Muscle Function in Type 1 Diabetes

NCT01816165

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-06-01

PhasePHASE3

Study timeline

Study start (unknown)2011-06-01Date precision: month

Registry last updated2022-01-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 1 Diabetesunresolved

Interventions

AcipimoxDRUG

PlaceboDRUG

Sponsors & collaborators

University of Colorado, Denverlead sponsor

Mapped research locations

AuroraColorado, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01816165 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.